Alpha-ketoglutarate (AKG) inhibits proliferation of colon adenocarcinoma cells in normoxic conditions

Scandinavian Journal of Gastroenterology

Volumn 47, Issue 5, 2012, Pages 565-571

  Rzeski, Wojciech ^a,b   Walczak, Katarzyna ^b   Juszczak, Małgorzata ^b   Langner, Ewa ^b   Pozlarowski, Piotr ^c   Kandefer Szerszeń, Martyna ^a   Pierzynowski, Stefan G ^b,d  

^a MARIA CURIE SK ODOWSKA UNIVERSITY   (Poland)

^b INSTITUTE OF AGRICULTURAL MEDICINE   (Poland)

^c MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^d LUND UNIVERSITY   (Sweden)

Author keywords

ketoglutarate; cell cycle; normoxia; P21 Waf1 Cip1; proliferation; Rb

Indexed keywords

2 OXOGLUTARIC ACID; CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 1B;

ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CANCER INHIBITION; CARCINOMA CELL; CELL CYCLE; CELL CYCLE ARREST; CELL PROLIFERATION; COLON ADENOCARCINOMA; CONTROLLED STUDY; DISEASE SEVERITY; G1 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CACO-2 CELLS; CELL CYCLE; CELL PROLIFERATION; CYCLIN D1; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASE INHIBITOR P27; HT29 CELLS; HUMANS; KETOGLUTARIC ACIDS; OXYGEN; PHOSPHORYLATION; RETINOBLASTOMA PROTEIN;

EID: 84859576496     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521.2012.660539     Document Type: Article

References (23)

1. Robinson LE, Bussiere FI, Le Boucher J, Farges MC, Cynober LA, Field CJ, et al. Amino acid nutrition and immune function in tumour-bearing rats: a comparison of glutamine-, arginine-, and ornithine 2-oxoglutaratesupplemented diets. Clin Sci (Lond) 1999;97:657-69. (Pubitemid 30018877)
2. Le Bricon T, Cynober L, Field CJ, Baracos VE. Supplemental nutrition with ornithine alpha-ketoglutarate in rats with cancer-associated cachexia: surgical treatment of the tumor improves efficacy of nutritional support. J Nutr 1995;125: 2999-3010.
3. Harris AL. Hypoxia-a key regulatory factor in tumour growth. Nat Rev 2002;2:38-47. (Pubitemid 37328806)
4. Matsumoto K, Imagawa S, Obara N, Suzuki N, Takahashi S, Nagasawa T, et al. 2-Oxoglutarate downregulates expression of vascular endothelial growth factor and erythropoietin through decreasing hypoxia-inducible factor-1a and inhibits angiogenesis. J Cell Physiol 2006;209:333-40. (Pubitemid 44484623)
5. Matsumoto K, Obara N, Ema M, Horie M, Naka A, Takahashi S, et al. Antitumor effects of 2-oxoglutarate through inhibition of angiogenesis in a murine tumor model. Cancer Sci 2009;100:1639-47.
6. Rzeski W, Turski L, Ikonomidou C. Glutamate antagonists limit tumor growth. ProcNatl Acad Sci USA 2001;98:6372-7. (Pubitemid 32488244)
7. Blagosklonny MV, Darzynkiewicz Z, Halicka HD, Pozarowski P, Demidenko ZN, Barry JJ, et al. Paclitaxel induces primary and postmitotic G1 arrest in human arterial smooth muscle cells. Cell Cycle 2004;3:1050-6. (Pubitemid 40268664)
8. Walczak K, Dǎbrowski W, Langner E, Zgrajka W, Pilat J, Kocki T, et al. Kynurenic acid synthesis and kynurenine aminotransferases expression in colon derived normal and cancer cells. Scand J Gastroenterol 2011;46:903-12.
9. Litchfield JT, Wilcoxon FA. A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther 1949; 96:99-113.
10. Bertout JA, Patel SA, Simon MC. The impact of O2 availability on human cancer. Nat Rev Cancer 2008;8: 967-75.
11. Rademakers SE, Span PN, Kaanders JH, Sweep FC, van der Kogel AJ, Bussink J. Molecular aspects of tumour hypoxia. Mol Oncol 2008;2:41-53.
12. Tennant DA, Gottlieb E. HIF prolyl hydroxylase-3 mediates alpha-ketoglutarate-induced apoptosis and tumor suppression. J Mol Med 2010;88:839-49.
13. Meerana SM, Kumar Katiyar S. Cell cycle control as a basis for cancer chemoprevention through dietary agents. Front Biosci 2008;13:2191-202.
14. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D. p21 is a universal inhibitor of cyclin kinases. Nature 1993;366:701-4. (Pubitemid 24036020)
15. Alkarain A, Jordan R, Slingerland J. p27 deregulation in breast cancer: prognostic significance and implications for therapy. J Mammary Gland Biol Neoplasia 2004; 9:67-80. (Pubitemid 39137497)
16. Alao JP. The regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic invention. Mol Cancer 2007;6:6-24.
17. Lemons JM, Feng XJ, Bennett BD, Legesse-Miller A, Johnson EL, Raitman I, et al. Quiescent fibroblasts exhibit high metabolic activity. PLoS Biol 2010;8:e1000514.
18. Hou Y, Wang L, Ding B, Liu Y, Zhu H, Liu J, et al. Dietary alpha-ketoglutarate supplementation ameliorates intestinal injury in lipopolysaccharide-challenged piglets. Amino Acids 2010;39:555-64.
19. Yao K, Yin Y, Li X, Xi P, Wang J, Lei J, et al. Alphaketoglutarate inhibits glutamine degradation and enhances protein synthesis in intestinal porcine epithelial cells. Amino Acids 2011;DOI: 10.1007/s00726-011-1060-6. [Epub ahead of print]
20. Sarbassov DD, Ali SM, Sabatini DM. Growing roles for the mTOR pathway. Curr Opin Cell Biol 2005;17:596-603. (Pubitemid 41540408)
21. Vaisman N, Arber N. The role of nutrition and chemoprevention in colorectal cancer: from observations to expectations. Best Pract Res Clin Gastroenterol 2002;16:201-17.
22. Mukhopadhyay A, Banerjee S, Stafford LJ, Xia CX, Liu M, Aggarwal BB. Curcumin induced suppression of cell proliferation correlates with down regulation of cyclin D1 expression and CDK4-mediated retinoblastoma protein phosphorylation. Oncogene 2002;21:8852-61. (Pubitemid 36132405)
23. Estrov Z, Shishodia S, Faderl S, Harris D, Van Q, Kantarjian HM, et al. Resveratrol blocks interleukin-1 [beta]-induced activation of the nuclear transcription factor NF-[kappa]B, inhibits proliferation, causes S-phase arrest and induces apoptosis of acute myeloid leukemia cells. Blood 2003;102:987-95. (Pubitemid 36917794)